Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Inflation Reduction Act of 2022
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Monitoring the FY 2022 Appropriations and Reconciliation Process. Provisions included in Title I - Subtitle B of PL. 117-169/H.R. 5376 - Inflation Reduction Act of 2022.
Inflation Reduction Act of 2022
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2026 · second_quarter · Q2
Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.
Filing targets: HOUSE OF REPRESENTATIVES
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2026 · first_quarter · Q1
Source: Senate LDA
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act
Inflation Reduction Act of 2022
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act
Inflation Reduction Act of 2022
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Access to autologous cellular immunotherapies in Medicare Part B. Provisions included in Title I - Subtitle B of PL. 117-169/H.R. 5376 - Inflation Reduction Act of 2022. Monitoring the FY 2023 Appropriations and FY 2022 Reconciliation Process.
Lower Costs, More Cures Act of 2021
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Lower Costs, More Cures Act of 2021
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Lower Costs, More Cures Act of 2021
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129) Build Back Better Act (HR 5376)
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129) Build Back Better Act (HR 5376)
Inflation Reduction Act of 2022
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act
Inflation Reduction Act of 2022
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129) Build Back Better Act (HR 5376)
M.H. Dutch Salmon Greater Gila Wild and Scenic River Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129) Build Back Better Act (HR 5376)
M.H. Dutch Salmon Greater Gila Wild and Scenic River Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
M.H. Dutch Salmon Greater Gila Wild and Scenic River Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Prescription Drug Pricing Reduction Act of 2020
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129) Build Back Better Act (HR 5376)
Prescription Drug Pricing Reduction Act of 2020
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Prescription Drug Pricing Reduction Act of 2020
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Veteran's Prostate Cancer Treatment and Research Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Veteran's Prostate Cancer Treatment and Research Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Veteran's Prostate Cancer Treatment and Research Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Veteran's Prostate Cancer Treatment and Research Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Lower Costs, More Cures Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 19 - the Lower Costs, More Cures Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 19 - the Lower Costs, More Cures Act of 2019.
Elijah E. Cummings Lower Drug Costs Now Act
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Prescription Drug Pricing Reduction Act of 2019
Client: DENDREON PHARMACEUTICALS, LLC · Firm: DENDREON PHARMACEUTICALS, LLC
Prostate Cancer treatment and Medicare Part B payment reform. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 19 - the Lower Costs, More Cures Act of 2019.
Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.
Filing targets: HOUSE OF REPRESENTATIVES
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2025 · fourth_quarter · Q4
Issues related to the Department of Veterans Affairs National Oncology Program's Prostate Cancer Oncology Clinical Pathway.
Filing targets: HOUSE OF REPRESENTATIVES
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2025 · third_quarter · Q3
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2025 · second_quarter · Q2
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2025 · first_quarter · Q1
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2024 · fourth_quarter · Q4
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2024 · third_quarter · Q3
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2024 · second_quarter · Q2
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2024 · first_quarter · Q1
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2023 · fourth_quarter · Q4
Access to autologous cellular immunotherapies in Medicare Part B. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2023 · third_quarter · Q3
Issues related to prostate cancer Access to autologous cellular immunotherapies in Medicare Part B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2023 · second_quarter · Q2
Issues related to prostate cancer Access to autologous cellular immunotherapies in Medicare Part B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2023 · first_quarter · Q1
Issues related to prostate cancer Access to autologous cellular immunotherapies in Medicare Part B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2022 · fourth_quarter · Q4
Access to autologous cellular immunotherapies in Medicare Part B. Provisions included in Title I - Subtitle B of PL. 117-169/H.R. 5376 - Inflation Reduction Act of 2022. Monitoring the FY 2023 Appropriations and FY 2022 Reconciliation Process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2022 · third_quarter · Q3
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Monitoring the FY 2022 Appropriations and Reconciliation Process. Provisions included in Title I - Subtitle B of PL. 117-169/H.R. 5376 - Inflation Reduction Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2022 · second_quarter · Q2
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2022 · first_quarter · Q1
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2021 · fourth_quarter · Q4
Medicare Part B drug payment reform. Specifically, access to autologous cellular immunotherapies in Medicare Part B Access to Prostate Cancer Treatment Provisions included in Subtitle J of H.R. 5376 - Build Back Better Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2021 · third_quarter · Q3
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129) Build Back Better Act (HR 5376)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2021 · second_quarter · Q2
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2021 · first_quarter · Q1
Medicare Part B drug payment reform Elijah E. Cummings Lower Drug Costs Now Act (HR 3) Prescription Drug Pricing Reduction Act of 2020 (S 4199) Lower Costs, More Cures Act of 2021 (HR 19)(S 3129)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2020 · fourth_quarter · Q4
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2020 · third_quarter · Q3
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2020 · second_quarter · Q2
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2020 · first_quarter · Q1
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019. H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2019 · third_quarter · 3A
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2019 · second_quarter · 2A
Access to prostate cancer immunotherapy at the Veterans Health Administration
Filing targets: HOUSE OF REPRESENTATIVES
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2019 · fourth_quarter · Q4
Prostate Cancer treatment and Medicare Part B payment reform. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 19 - the Lower Costs, More Cures Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2019 · third_quarter · Q3
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2019 · second_quarter · Q2
Access to prostate cancer immunotherapy at the Veterans Health Administration
Filing targets: HOUSE OF REPRESENTATIVES
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2019 · second_quarter · RA
Medicare Part B payment reform Clinical pathway for prostate cancer at the VA
Medicare Part B payment reform Clinical pathway for prostate cancer at the VA
DENDREON PHARMACEUTICALS, LLC via DENDREON PHARMACEUTICALS, LLC
2019 · second_quarter · RR
Medicare Part B Payment Reform